In Vivo PK - ESMO

JAX's HuPK platform is an efficient, accessible, and predictive platform for determining the PK profile of mAbs, bispecifics, ADCs, and albumin conjugates. An alternative to non-human primates, HuPK models closely mimic human PK values and facilitate the determination of first-in-human doses to speed therapeutic development.